Clinical Trial Update: Interferon Treatment for Patients With Chronic Hepatitis C and End Stage Renal Disease [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating interferon treatment for chronic hepatitis C in patients with end-stage renal disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Hepatitis C

Drugs mentioned

• Interferon Alfa (interferon alfa)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Chronic Hepatitis C, End Stage Renal Disease | Phase 4 | Status: COMPLETED